Clinical Trial Update: Safety and Efficacy of TTFields (150 kHz) Concomitant With Pemetrexed and Cisplatin or Carboplatin in Malignant Pleural Mesothelioma (STELLAR) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating TTFields (150 kHz) with pemetrexed and platinum in malignant pleural mesothelioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)
• Pemetrexed (pemetrexed)
• TTFields (150 kHz)

Snippet

Sponsor: NovoCure Ltd. | Conditions: Malignant Pleural Mesothelioma | Phase 2 | Status: COMPLETED